HOLLAND & KNIGHT LLP

Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical Company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $20,000.00 income · posted Apr 10, 2026

Lobbying activity 1

Taxation/Internal Revenue Code

Tax Reform - Restoring the Orphan Drug Tax Credit.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem